drugset / Trial / NCT01400620

Safety and Efficacy of IZN-6N4 Oral Rinse for the Prevention of Oral Mucositis in Patients With Head and Neck Cancer

NCT01400620 ↗

Phase 2 Completed 110 enrolled Izun Pharma Ltd
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to determine whether an oral rinse composed of botanical extracts is effective in the prevention of severe inflammation of the lining of the oral cavity caused by chemotherapy and radiation therapy for head and neck cancer.

Timeline

Start
2012-03
Primary completion
2017-01
Completion
2017-01

Drugs

EvaluationDrugModalityDoseRoute
Subject IZN-6N4 Unknown 1 % Oral
Subject IZN-6N4 Unknown 15 ml Oral

Indications